TW203012B - - Google Patents

Download PDF

Info

Publication number
TW203012B
TW203012B TW080105605A TW80105605A TW203012B TW 203012 B TW203012 B TW 203012B TW 080105605 A TW080105605 A TW 080105605A TW 80105605 A TW80105605 A TW 80105605A TW 203012 B TW203012 B TW 203012B
Authority
TW
Taiwan
Prior art keywords
percent
desirably
item
composition
oil
Prior art date
Application number
TW080105605A
Other languages
English (en)
Chinese (zh)
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of TW203012B publication Critical patent/TW203012B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW080105605A 1990-07-20 1991-07-19 TW203012B (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU904564A HUT59592A (en) 1990-07-20 1990-07-20 Process for the preparation of solid medical products

Publications (1)

Publication Number Publication Date
TW203012B true TW203012B (ko) 1993-04-01

Family

ID=10968329

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080105605A TW203012B (ko) 1990-07-20 1991-07-19

Country Status (22)

Country Link
JP (1) JPH04253924A (ko)
KR (1) KR920002162A (ko)
BE (1) BE1006829A3 (ko)
CA (1) CA2047482A1 (ko)
CH (1) CH681960A5 (ko)
CY (1) CY1840A (ko)
CZ (1) CZ280064B6 (ko)
DE (1) DE4124081A1 (ko)
DK (1) DK137591A (ko)
ES (1) ES2039177B1 (ko)
FI (1) FI913493A (ko)
FR (1) FR2664814B1 (ko)
GB (1) GB2246072B (ko)
GR (1) GR1002175B (ko)
HU (1) HUT59592A (ko)
IL (1) IL98894A0 (ko)
IT (1) IT1250681B (ko)
NL (1) NL9101268A (ko)
SE (1) SE9102160L (ko)
TW (1) TW203012B (ko)
YU (1) YU47573B (ko)
ZA (1) ZA915677B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411115D0 (en) * 1994-06-03 1994-07-27 Secr Defence Stabilisation of photosensitive material
WO1996033701A1 (en) * 1995-04-24 1996-10-31 Pfizer Inc. Inhibiting photodecomposition of 3-substituted-2-oxindoles
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
JP3549522B1 (ja) * 2003-10-24 2004-08-04 日清ファルマ株式会社 コエンザイムｑ１０含有カプセル剤
WO2010038771A1 (ja) * 2008-09-30 2010-04-08 中外製薬株式会社 光安定化された医薬組成物
CA2968861C (en) 2017-05-30 2022-10-11 University Of Saskatchewan Topical nifedipine formulations and uses thereof
KR200489660Y1 (ko) * 2018-02-09 2019-07-19 김순희 퍼팅연습기

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55127448A (en) * 1979-03-23 1980-10-02 Chugai Pharmaceut Co Ltd Gelatin coating
JPS6043046B2 (ja) * 1979-04-24 1985-09-26 パ−ク・デ−ビス・エンド・コンパニ− ゼラチンカプセル
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
ATE33348T1 (de) * 1983-11-30 1988-04-15 Siegfried Ag Coronartherapeutikum in form von weichgelatinekapseln.
JPS61225109A (ja) * 1985-03-29 1986-10-06 Shiseido Co Ltd カラメル含有組成物
DE3526546A1 (de) * 1985-07-25 1987-01-29 Scherer Gmbh R P Lichtbestaendige opakisierte gelatinekapseln und verfahren zur herstellung derselben
DE3532129A1 (de) * 1985-09-10 1987-03-12 Bayer Ag Ss-carotin enthaltende gelatine
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
EP0272336B1 (de) * 1986-12-18 1991-10-23 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung
JPS63215641A (ja) * 1987-03-05 1988-09-08 Toyo Jozo Co Ltd ゼラチン皮膜組成物
JPH01218573A (ja) * 1988-02-25 1989-08-31 Yoshio Tanaka ドナリエラ藻体含有固形状食品の製造法

Also Published As

Publication number Publication date
JPH04253924A (ja) 1992-09-09
ES2039177B1 (es) 1994-03-16
YU47573B (sh) 1995-10-03
GR910100319A (el) 1992-08-26
KR920002162A (ko) 1992-02-28
ITMI912002A1 (it) 1993-01-19
CZ280064B6 (cs) 1995-10-18
YU127191A (sh) 1994-05-10
SE9102160L (sv) 1992-01-21
CH681960A5 (ko) 1993-06-30
ZA915677B (en) 1993-03-31
ES2039177A1 (es) 1993-09-01
FI913493A (fi) 1992-01-21
CY1840A (en) 1996-03-08
DK137591D0 (da) 1991-07-19
BE1006829A3 (fr) 1995-01-03
DK137591A (da) 1992-01-21
NL9101268A (nl) 1992-02-17
FR2664814A1 (fr) 1992-01-24
IL98894A0 (en) 1992-07-15
HU904564D0 (en) 1990-12-28
GR1002175B (en) 1996-03-07
GB2246072B (en) 1994-06-15
DE4124081A1 (de) 1992-01-23
FI913493A0 (fi) 1991-07-19
SE9102160D0 (sv) 1991-07-10
HUT59592A (en) 1992-06-29
GB9115693D0 (en) 1991-09-04
FR2664814B1 (fr) 1995-05-24
IT1250681B (it) 1995-04-21
GB2246072A (en) 1992-01-22
CS222291A3 (en) 1992-02-19
CA2047482A1 (en) 1992-01-21
ITMI912002A0 (it) 1991-07-19

Similar Documents

Publication Publication Date Title
US4070494A (en) Enteral pharmaceutical compositions
EP0277459B1 (de) Arzneimittel mit verzögerter Wirkstofffreisetzung
TW587936B (en) Pharmaceutical composition containing proton pump inhibitors
JP2000514406A (ja) アルギン酸から成る経口投与製剤用腸溶性被膜
TW201114766A (en) Pharmaceutical composition for a hepatitis C viral protease inhibitor
DE69723248T2 (de) Vergällungsstoffe für sympathomimetische aminsalze
CH679011A5 (ko)
US8420700B1 (en) Tamper resistant lipid-based oral dosage form for sympathomimetic amines
TW203012B (ko)
JP2008511555A (ja) 鎮痛作用を有する薬物
NZ270439A (en) Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
CA2137764C (en) Pharmaceutical compositions comprising solutions or dispersions of a staurosporine active ingredient in a saturated polyalkylene glycol glyceride
FR2508313A1 (fr) Nouvelles formulations pharmaceutiques a base d'alcaloides de l'ergot de seigle et leur preparation
NO303669B1 (no) FremgangsmÕte for fremstilling av en tablett eller dragÚpreparat
TWI260224B (en) Pharmaceutical compositions for the treatment of tumor diseases
TWI286072B (en) Sleeping medicine formed by coating solid
DE10392718T5 (de) Pharmazeutische Formulierung in einem Medikamentenfreisetzungssystem und Verfahren zur Herstellung derselben
EP0523153B1 (fr) Gelule huileuse de ketoprofene
EA015440B1 (ru) Твердая лекарственная форма, содержащая полиморфную форму 1 клопидогрела гидросульфата
JPS6140647B2 (ko)
EP1137653A1 (fr) Troxerutine a forte teneur en trihydroxy-ethyl-rutoside et procede de preparation
KR100201907B1 (ko) 비페닐디메틸디카르복실레이트를 가용화시킨 연질캅셀제
MXPA03002013A (es) Comprimidos que contienen epinatina fabricados por compresion directa.
KR100201906B1 (ko) 파모티딘을 가용화시킨 내용물을 함유한 연질캅셀제
US3361627A (en) Phenothiazine compositions